RecruitingNCT06058702
How genes relate to cannabis sensitivity and health effects
About this title
Read the official source — NCT06058702Medication studyAges 21–60United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 21 years to 60 years.
What will I do during this study?
This research study examines how genetic factors relate to cannabis exposure and its effects. The listed study groups receive different intravenous THC exposures, including a very low dose, a medium dose, or a placebo (an inactive comparison treatment) control. The public record does not provide enough clear visit-by-visit detail to describe the full participant schedule.
- Listed locations
- West HavenSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 16, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 215
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 21 Years to 60 Years
- Official registry ID
- NCT06058702
- Official title
Show the full official title
Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
West Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Does this study involve medication?
Yes. The study involves medication, including Delta-9-THC Very Low Dose, Placebo and Delta-9-THC Medium Dose.
Who can participate?
Listed age limits: 21 years to 60 years.
Is this study still recruiting?
The registry lists this study as recruiting.
